VEXTF (Vext Science) FCF Margin %: 9.83% (As of Mar. 2026) — 103% Above Median


VEXTF Vext Science Inc VEXTF
69 GF Score
Price $0.18
GF Value $1.06
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Vext Science FCF Margin %?

Vext Science VEXTF -3.15% 69 FCF Margin % is 9.83% as of Mar. 2026, which is 103% above its 10-year median of 4.85. GuruFocus rates VEXTF with a GF Score™ of 69/100 and a GF Value™ of $1.06 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 955 Drug Manufacturers companies, Vext Science ranks better than 78.32% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vext Science's Free Cash Flow for the three months ended in Mar. 2026 was $1.20 Mil. Vext Science's Revenue for the three months ended in Mar. 2026 was $12.16 Mil. Therefore, Vext Science's FCF Margin % for the quarter that ended in Mar. 2026 was 9.83%.

As of today, Vext Science's current FCF Yield % is 16.32%.

The historical rank and industry rank for Vext Science's FCF Margin % or its related term are showing as below:

VEXTF' s FCF Margin % Range Over the Past 10 Years
Min: -25.33   Med: 4.85   Max: 15.86
Current: 13.61


During the past 9 years, the highest FCF Margin % of Vext Science was 15.86%. The lowest was -25.33%. And the median was 4.85%.

VEXTF's FCF Margin % is ranked better than
78.32% of 955 companies
in the Drug Manufacturers industry
Industry Median: 2.51 vs VEXTF: 13.61


Vext Science FCF Margin % Related Terms


Vext Science FCF Margin % Historical Data

* Premium members only.

The historical data trend for Vext Science's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vext Science FCF Margin % Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only -20.21 -8.86 4.85 5.07 15.86

Vext Science Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.62 25.32 1.07 17.09 9.83

VEXTF vs ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vext Science FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vext Science's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vext Science's FCF Margin % falls into.


VEXTF
69GF Score
Vext Science Inc VEXTF
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vext Science FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vext Science's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=8.145/51.367
=15.86 %

Vext Science's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=1.195/12.16
=9.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 9.83% mean?
Vext Science (VEXTF) has a FCF Margin % of 9.83% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vext Science and its competitors. This is 103% above median its historical median of 4.85. According to the industry distribution chart, Vext Science ranks #207 out of 955 companies in the Drug Manufacturers industry, placing it in the top 21.7%.
Is Vext Science's FCF Margin % too high?
Vext Science's current FCF Margin % of 9.83% is 103% above median its 10-year median of 4.85. The Drug Manufacturers industry median FCF Margin % is 2.51. Vext Science's value of 9.83% is 291.6% above this industry median. Based on the distribution chart, Vext Science ranks #207 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vext Science has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vext Science's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vext Science ranks #207 out of 955 companies for FCF Margin %. This places Vext Science in the top 22% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Vext Science's value of 9.83% is 291.6% above this benchmark. While the company's 10-year median is 4.85 vs. the industry median of 2.51, Vext Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vext Science's current FCF Margin % of 9.83% is 291.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vext Science and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vext Science's current FCF Margin % is 9.83%, which is 103% above median its own 10-year median of 4.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vext Science stock overvalued right now?
Based on GuruFocus' analysis, Vext Science (VEXTF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.06, compared to a current price of $0.18 — trading 83.2% below its estimated fair value. The current FCF Margin % is 9.83%, which is 103% above median its 10-year median of 4.85 and 291.6% above the Drug Manufacturers industry median of 2.51. Vext Science's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vext Science (VEXTF), the current FCF Margin % is 9.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vext Science (VEXTF) Overvalued in 2026?

Based on GuruFocus' analysis, Vext Science stock appears to be undervalued. The current stock price of $0.18 is trading 83.2% below its estimated GF Value™ of $1.06. GuruFocus considers Vext Science to be Possible Value Trap.

Key valuation signals for VEXTF:

  • FCF Margin %: 9.83% (103% above median its 10-year median of 4.85)
  • GF Value™: $1.06 vs. price of $0.18 (83.2% below fair value)
  • GF Score™: 69/100 with 3 warning signs
  • Industry Position: 291.6% above the Drug Manufacturers median (#207 of 955)

No single metric tells the full story. See the VEXTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vext Science Business Description

Other Exchanges VEXT:Canada
Address 4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Vext Science Inc engages in the full spectrum of the cannabis product lifecycle, from development and manufacturing to distribution. Its brands include Herbal Wellness, Appalachian Pharm, Revibe, Prism, Vapen, and Firebrand. In Arizona and Ohio, the dispensaries operate under the Herbal Wellness Center brand, while in Ohio the cultivation and manufacturing operations are licensed and branded as Appalachian Pharms Cultivation and Appalachian Pharm Processing. The Company operates through a single operating segment engaged in the cultivation, manufacturing, distribution, and sale of cannabis within the United States. All revenues are generated in the United States.
69GF Score

Get the complete analysis for VEXTF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.18
Price
$1.06
GF Value